Holt brings valuable experience having co-founded Aiolos Bio Inc, which GSK acquired for $1.4 billion ... and chief medical officer. The Waltham, Massachusetts clinical-stage biopharma, which ...

Waltham, Massachusetts-based Blue Oak ... Bristol-Myers Squibb’s Celgene unit, Sanofi, GlaxoSmithKline, and Roche – have bought into the promise of its platform to accelerate drug ...

GSK has been found guilty of bringing discredit on the pharma industry after a complainant flagged “a shocking error” in the prescribing information for the JAK inhibitor Omjjara. A person who ...

GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022. The U.K.’s Medicines and Healthcare products Regulatory Agency ...

At its 52-week peak on 16 May 2024, the GSK share price hit 1,823.5p, but it’s been mostly downhill ever since. Last week, as stock markets crashed, GSK shares collapsed to 1,242.5p on Wednesday 9 ...

April 15 (Reuters) - British pharmaceutical giant GSK (GSK.L), opens new tab has not met required ethical and regulatory standards in the marketing and prescription information for its Omjjara ...

(Alliance News) - GSK PLC on Thursday said it has received authorisation from the UK Medicines & Healthcare products Regulatory Agency for Blenrep combinations in the treatment of adults with ...

Goldman Sachs said Monday that GSK (NYSE:GSK) is set for a 'positive surprise' this week as a CDC Advisory Committee is scheduled to discuss whether to broaden the recommendation for Arexvy ...

In spring 2021, my family sold a big lump of GSK shares. Four years later, we have no regrets. Indeed, with the GSK share price stumbling, we may buy soon. When investing, your capital is at risk.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...